Arthroplasty Replacement, Knee, Arthroplasty Total Hip Replacement
Conditions
Keywords
Chlorohexidine Gluconate, Incise drape, CHG, Ioban
Brief summary
The goal of this clinical study is to generate data on the intended use of a chlorhexidine gluconate (CHG)-impregnated antimicrobial incise drape. The study includes subjects undergoing primary hip or knee arthroplasty procedures. The study evaluates the intraoperative performance and safety of the incise drape during surgery, including assessment of contamination and operative characteristics. Participants will have a CHG-impregnated antimicrobial incise drape applied during their surgical procedure. During surgery, samples will be collected from the operative site to assess potential bacterial contamination.
Detailed description
This is a prospective, single-arm clinical study conducted in the United States in subjects undergoing primary hip or knee arthroplasty. The study evaluates the intraoperative performance and safety of a chlorhexidine gluconate (CHG)-impregnated antimicrobial incise drape used during lower extremity orthopedic surgery. Safety and intraoperative performance outcomes will be assessed throughout the study.
Interventions
DEVICE3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape (2% w/w CHG)
A CHG-impregnated antimicrobial incise drape applied to the surgical site prior to incision during primary hip or knee arthroplasty.
Sponsors
Solventum US LLC
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Subject is ≥ 22 years of age on the day of surgery. * Subject is scheduled to undergo a unilateral primary arthroplasty procedure on a hip or knee. * Subject is capable of providing informed consent. * Subject is willing and able to return for all visits.
Exclusion criteria
* Subject is pregnant or lactating prior to surgery.\* \*Women who have had surgical sterilization by a medically accepted method (e.g., tubal ligation, hysterectomy, or oophorectomy) or are post-menopausal, defined as not having menstruation for \> 12 months will not be required to undergo pregnancy testing * Subject is scheduled to undergo a lower extremity bilateral arthroplasty procedure. * Subject had a previous open knee surgery on the study knee or is scheduled to undergo a revision knee arthroplasty. * Subject has had a previous surgery for revision femoral acetabular osteotomy or total hip arthroplasty on the study hip. * Subject is scheduled for lower extremity arthroplasty due to trauma. * Subject was previously diagnosed with septic arthritis or has a history of infection in the joint. * Subject has taken any antibiotics within 4 weeks before surgery. * Subject has an allergy or sensitivity to components of the device (e.g., chlorhexidine gluconate or acrylate-based adhesive). * Subject is currently enrolled in another trial.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluation of the presence of contamination at the surgical site during the operative procedure. | During surgery | Assessment of contamination at the surgical site during the operative procedure. |
Countries
United States
Contacts
CONTACTTracy E Swanson
CONTACTStephanie Karwedsky
Outcome results
None listed